142 related articles for article (PubMed ID: 236316)
1. [127-I]- or carrier-free [125-I]monoiodoinsulin.
Sodoyez JC; Sodoyez-Goffaux F; Goff MM; Zimmerman AE; Arquilla ER
J Biol Chem; 1975 Jun; 250(11):4268-77. PubMed ID: 236316
[TBL] [Abstract][Full Text] [Related]
2. Monoiodoinsulin. Preparation, purification, and characterization of a biologically active derivative substituted predominantly on tyrosine A14.
Hamlin JL; Arquilla ER
J Biol Chem; 1974 Jan; 249(1):21-32. PubMed ID: 4809628
[No Abstract] [Full Text] [Related]
3. Tyrosine A14[125I]monoiodoinsulin: Preparation, Biologic Properties, and long-term stability.
Linde S; Hansen B; Sonne O; Holst JJ; Gliemann J
Diabetes; 1981 Jan; 30(1):1-8. PubMed ID: 7014299
[TBL] [Abstract][Full Text] [Related]
4. Monoiodoinsulin: demonstration of its biological activity and binding to fat cells and liver membranes.
Freychet P; Roth J; Neville DM
Biochem Biophys Res Commun; 1971 Apr; 43(2):400-8. PubMed ID: 5577450
[No Abstract] [Full Text] [Related]
5. Chicken insulin: radioimmunological characterization and enhanced activity in rat fat cells and liver plasma membranes.
Simon J; Freychet P; Rosselin G
Endocrinology; 1974 Nov; 95(5):1439-49. PubMed ID: 4372041
[No Abstract] [Full Text] [Related]
6. [Radioligand assay: methods and application. V. Mono-125I-insulin: preparation and immunological and biological characterization].
Besch W; Woltanski KP; Knospe S; Ziegler M; Keilacker H
Acta Biol Med Ger; 1980; 39(4):495-502. PubMed ID: 7004036
[TBL] [Abstract][Full Text] [Related]
7. Monoiodoinsulin specifically substituted in Tyr A14 or Tyr A19.
Linde S; Hansen B
Int J Pept Protein Res; 1980 May; 15(5):495-502. PubMed ID: 7002822
[TBL] [Abstract][Full Text] [Related]
8. Preparation and characterization of monoiodoinsulin.
Linde S; Hansen B
Int J Pept Protein Res; 1974; 6(3):157-63. PubMed ID: 4415172
[No Abstract] [Full Text] [Related]
9. Degradation, receptor binding affinity and biological potency of monoiodoinsulin in isolated rat fat cells.
Gammeltoft S; Vinten J; Gliemann J; Linde S
Horm Metab Res; 1977 May; 9(3):186-9. PubMed ID: 885469
[TBL] [Abstract][Full Text] [Related]
10. [Heterogeneity of the immunoreactivity of A14, A19, B16 and B26- (125I) monoiodoinsulin to different species of anti-insulin immuno sera].
Zhou W; Li S; Deng S
Hua Xi Yi Ke Da Xue Xue Bao; 1993 Dec; 24(4):369-72. PubMed ID: 8150434
[TBL] [Abstract][Full Text] [Related]
11. Degradation of insulin and insulin-like growth factors by enzyme purified from human erythrocytes. Comparison of degradation products observed with A14- and B26-[125I]monoiodoinsulin.
Misbin RI; Almira EC
Diabetes; 1989 Feb; 38(2):152-8. PubMed ID: 2644137
[TBL] [Abstract][Full Text] [Related]
12. Triacetylated insulin: biologic activity and resistance to degradation.
Kaplan SA; Morris JW; Davidson MB; Gerschenson LE; Scott M
Metabolism; 1976 Nov; 25(11):1209-16. PubMed ID: 10504
[TBL] [Abstract][Full Text] [Related]
13. Comparison of radiochemical purity and tissue binding of labelled insulin prepared by lactoperoxidase and chloramine T iodination.
Zórad S; Svábová E; Klimes I; Macho L
Endocrinol Exp; 1985 Dec; 19(4):267-75. PubMed ID: 3910407
[TBL] [Abstract][Full Text] [Related]
14. Monoiodoinsulin labelled in tyrosine residue 16 or 26 of the B-chain or 19 of the A-chain. II. Characterization of the kinetic binding constants and determination of the biological potency.
Sonne O; Linde S; Larsen TR; Gliemann J
Hoppe Seylers Z Physiol Chem; 1983 Feb; 364(2):101-10. PubMed ID: 6341199
[TBL] [Abstract][Full Text] [Related]
15. Iodoglucagon. Preparation and characterization.
Desbuquois B
Eur J Biochem; 1975 May; 53(2):569-80. PubMed ID: 1140201
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like activity by fat pad assay and immunoreactive insulin. I. Their correlation in native serum acid-ethanol extract and salt-ethanol extract.
Ide T; Kuzuya T; Kajinuma H; Kanazawa Y; Kosaka K
Diabetes; 1969 Feb; 18(2):65-74. PubMed ID: 5763662
[No Abstract] [Full Text] [Related]
17. A14-[125I]monoiodoinsulin purified by different high-performance liquid chromatographic procedures and by polyacrylamide gel electrophoresis: preparation, immunochemical properties and receptor binding affinity.
Benzi L; Pezzino V; Marchetti P; Gullo D; Cecchetti P; Masoni A; Vigneri R; Navalesi R
J Chromatogr; 1986 Jun; 378(2):337-47. PubMed ID: 3525587
[TBL] [Abstract][Full Text] [Related]
18. Insulin receptors in the liver: specific binding of ( 125 I)insulin to the plasma membrane and its relation to insulin bioactivity.
Freychet P; Roth J; Neville DM
Proc Natl Acad Sci U S A; 1971 Aug; 68(8):1833-7. PubMed ID: 4331561
[TBL] [Abstract][Full Text] [Related]
19. [125I]diiodoinsulins. Binding affinities, biologic potencies, and properties of their decay products.
Pérez Maceda B; Linde S; Sonne O; Gliemann J
Diabetes; 1982 Jul; 31(7):634-40. PubMed ID: 7160541
[TBL] [Abstract][Full Text] [Related]
20. Immunological and biological properties of iodoinsulin labeled with one or less atoms of iodine per molecule.
Arquilla ER; Ooms H; Mercola K
J Clin Invest; 1968 Mar; 47(3):474-87. PubMed ID: 5637137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
